These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11157481)

  • 1. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.
    Bhagwat SV; Lahdenranta J; Giordano R; Arap W; Pasqualini R; Shapiro LH
    Blood; 2001 Feb; 97(3):652-9. PubMed ID: 11157481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis.
    Bhagwat SV; Petrovic N; Okamoto Y; Shapiro LH
    Blood; 2003 Mar; 101(5):1818-26. PubMed ID: 12406907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells.
    Mishima Y; Terui Y; Sugimura N; Matsumoto-Mishima Y; Rokudai A; Kuniyoshi R; Hatake K
    Cancer Sci; 2007 Mar; 98(3):364-72. PubMed ID: 17270026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD13/APN transcription is induced by RAS/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells.
    Petrovic N; Bhagwat SV; Ratzan WJ; Ostrowski MC; Shapiro LH
    J Biol Chem; 2003 Dec; 278(49):49358-68. PubMed ID: 14507917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer.
    Hashida H; Takabayashi A; Kanai M; Adachi M; Kondo K; Kohno N; Yamaoka Y; Miyake M
    Gastroenterology; 2002 Feb; 122(2):376-86. PubMed ID: 11832452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myb and Ets proteins cooperate to transactivate an early myeloid gene.
    Shapiro LH
    J Biol Chem; 1995 Apr; 270(15):8763-71. PubMed ID: 7721782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired angiogenesis in aminopeptidase N-null mice.
    Rangel R; Sun Y; Guzman-Rojas L; Ozawa MG; Sun J; Giordano RJ; Van Pelt CS; Tinkey PT; Behringer RR; Sidman RL; Arap W; Pasqualini R
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4588-93. PubMed ID: 17360568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lymphocytic aminopeptidase N/CD13 promoter activity after cell-cell contact.
    Kehlen A; Olsen J; Langner J; Riemann D
    J Cell Biochem; 2000 Sep; 80(1):115-23. PubMed ID: 11029758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD13/APN transcription is regulated by the proto-oncogene c-Maf via an atypical response element.
    Mahoney KM; Petrovic N; Schacke W; Shapiro LH
    Gene; 2007 Nov; 403(1-2):178-87. PubMed ID: 17897790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD13/APN regulates endothelial invasion and filopodia formation.
    Petrovic N; Schacke W; Gahagan JR; O'Conor CA; Winnicka B; Conway RE; Mina-Osorio P; Shapiro LH
    Blood; 2007 Jul; 110(1):142-50. PubMed ID: 17363739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) by interferon-gamma on the HL-60 cell line.
    Gabrilovac J; Breljak D; Cupić B; Ambriović-Ristov A
    Life Sci; 2005 Apr; 76(23):2681-97. PubMed ID: 15792835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cNGR: a novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo.
    Buehler A; van Zandvoort MA; Stelt BJ; Hackeng TM; Schrans-Stassen BH; Bennaghmouch A; Hofstra L; Cleutjens JP; Duijvestijn A; Smeets MB; de Kleijn DP; Post MJ; de Muinck ED
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2681-7. PubMed ID: 16990557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma.
    Otsuki T; Nakashima T; Hamada H; Takayama Y; Akita S; Masuda T; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Miyake M; Kohno N; Okada M; Hattori N
    Eur Respir J; 2018 May; 51(5):. PubMed ID: 29519924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
    Pasqualini R; Koivunen E; Kain R; Lahdenranta J; Sakamoto M; Stryhn A; Ashmun RA; Shapiro LH; Arap W; Ruoslahti E
    Cancer Res; 2000 Feb; 60(3):722-7. PubMed ID: 10676659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression.
    Kato M; Azuma H; Akaike M; Iuchi T; Aihara K; Ikeda Y; Fujimura M; Yoshida T; Yamaguchi H; Hashizume S; Matsumoto T
    Atherosclerosis; 2005 Nov; 183(1):49-55. PubMed ID: 16216591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.
    Akita S; Hattori N; Masuda T; Horimasu Y; Nakashima T; Iwamoto H; Fujitaka K; Miyake M; Kohno N
    Cancer Sci; 2015 Jul; 106(7):921-8. PubMed ID: 25950387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells.
    Kwon HJ; Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Yu J
    Jpn J Cancer Res; 2002 Apr; 93(4):417-25. PubMed ID: 11985792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.
    Guzman-Rojas L; Rangel R; Salameh A; Edwards JK; Dondossola E; Kim YG; Saghatelian A; Giordano RJ; Kolonin MG; Staquicini FI; Koivunen E; Sidman RL; Arap W; Pasqualini R
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1637-42. PubMed ID: 22307623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The main neutral aminopeptidase activity of human lymphoid tumour cell lines does not originate from the aminopeptidase N-(APN; CD13) gene.
    Wex T; Lendeckel U; Kähne T; Ittenson A; Frank K; Ansorge S
    Biochim Biophys Acta; 1997 Feb; 1355(2):147-54. PubMed ID: 9042335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis.
    Zheng YB; Gong JH; Liu XJ; Li Y; Zhen YS
    Mol Carcinog; 2017 May; 56(5):1395-1404. PubMed ID: 27991698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.